跳至主要内容
临床试验/NCT05240833
NCT05240833Unknown不适用

VExUS-guided Fluid Management in Patients With Acute Kidney Injury in the Intensive Care Unit

Hospital de Clinicas de Porto Alegre2 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2022年1月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
55
试验地点
2
主要终点
Renal replacement therapy

研究概览

简要总结

A quasi experimental study that aims to verify whether the incorporation of VExUS in patients with AKI in the Intensive Care Unit (ICU) may prompt tailored interventions to increases the number of days free from Renal Replacement Therapy (RRT) during the first 28 days.

详细描述

Fluid overload is associated with organ dysfunction, such as Acute Kidney Injury (AKI), and increased mortality. It remains unclear if fluid overload is merely an epiphenomenon in critically ill patients or if organ congestion is a mediator of complications. Considering AKI related to fluid overload, diuretic therapy would reduce venous congestion and improve renal blood flow. The Venous Excess Ultrasound score (VExUS) identifies clinically significant venous congestion and indicates a high risk of post-operative AKI. This quasi-experimental study aims to verify whether the incorporation of VExUS in patients with AKI in the Intensive Care Unit (ICU) may prompt tailored interventions to increases the number of days free from Renal Replacement Therapy (RRT) during the first 28 days.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-elective ICU admission
  • Severe acute kidney injury (AKI) defined either: A ≥ 2-fold increase in serum creatinine from a known pre-morbid baseline or during the current hospitalization OR Urine output < 6.0 mL/kg over the preceding 12 hours

排除标准

  • Life-threatening indication of RRT (defined as intractable hyperkalaemia, acidosis, uraemic symptoms) at Day 0
  • RRT before recruitment
  • Use of Extracorporeal membrane oxygenation (ECMO)
  • Hepatic cirrhosis or other condition with portal hypertension
  • Lack of commitment to provide RRT as part of limitation of ongoing life support
  • Known pre-hospitalization advanced chronic kidney disease, defined by an estimated glomerular filtration rate < 30 mL/min/1.73 m2 or chronic RRT
  • Refusal to sign the informed consent form

结局指标

主要结局

Renal replacement therapy

时间窗: Day 28

Number of days free from renal replacement therapy during the first 28 days

次要结局

  • Mortality(Day 28)
  • KDIGO category for AKI(48 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

VExUS-guided Fluid Management in Patients With Acute... | 临床试验